Encefalopatía discirculatoria, revisión bibliográfica
DOI:
https://doi.org/10.56712/latam.v4i1.264Palabras clave:
diagnóstico, encefalopatías, etiología, fisiopatología, tratamiento primarioResumen
La encefalopatía discirculatoria, es una disfunción cerebral resultante de trastornos vasculares, que se asocian a alteraciones degenerativas, isquémicas y cambios del tejido cerebral, por lo cual constituye la forma crónica, progresiva y multifocal de las patologías cerebrovasculares. Generalmente se asocia a hipertensión, diabetes mellitus tipo 2, aterosclerosis, enfermedades arteriovertebrales o su combinación. Se manifiesta a través de 3 estadios clínicos que comprometen el estado de ánimo, lo cognitivo y estado psicoemocional del paciente, los métodos diagnósticos son de neuroimagen como tomografía computarizada, resonancia magnética, ecografía doppler transcraneal, coágulo grama, lipograma estos representan un rol fundamental en el diagnóstico. No obstante, su abordaje terapéutico está enfocado en la disminución de la progresión de la enfermedad, aumento de la microcirculación, la circulación cerebral general y proteger a las células del sistema nervioso central de la isquemia e hipoxia.
Descargas
Citas
Chernii T., Cherniy V., & Fokina D. (2022). Implementation of Quantitative Electroencephalography to Improve Efficacy of Diagnosis and Treatment Management of Chronic Cerebral Ischemia. Wiad
Frolov M., & Gasankhanova A. (2020). Features of the violation of light sensitivity of the retina in patients with chronic cerebral ischemia, depending on the stage of discirculatory encephalopathy against the background of the use of a neuropeptide. Ophthalmology,17(4),784-788.https://doi.org/10.18008/1816-5095-2020-4-784-788
Gavrilenko E., Sultanova Y., Demyashchenkova A., & Skvortsov V. (2020). Dyscirculatory encephalopathy in nursing practice / Dyscirculatory encephalopathy in nursing practice. Nurse,1, 86–89. https://doi.org/10.33920/med-05-2001-15
Juul S., Comstock B., Heagerty P., Mayock D., et al. (2018). High-Dose Erythropoietin for Asphyxia and Encephalopathy (HEAL): A Randomized Controlled Trial - Background, Aims, and Study Protocol. Neonatology,113(4),331–338. https://doi.org/10.1159/000486820
Levin O., Chimagomedova S., Polyakova T., Arablinsky A. (2018). 60 years of the concept of dyscirculatory encephalopathy: is it possible to pour new wine into old wineskins?. Journal of Neurology and Psychiatry, 6(2),13-26. https://doi.org/10.17116/jnevro201811806213
Lin, Y., & Liu H. (2020). Update on cerebral hyperperfusion syndrome. Journal of neurointerventional surgery, 12(8), 788-793. https://doi.org/10.1136/neurintsurg-2019-015621
Nikitina V., Bochkov A., Guseva V. (2020). Comparative analysis of neurological, laboratory and instrumental studies of female patients with stage C dyscirculatory encephalopathy and without hyperhomocysteinemia. Newsletter of New Medical Technologies, 3, 5-10.https://cyberleninka.ru/article/n/sravnitelnyy-analiz-nevrologicheskih-laboratornyh-i-instrumentalnyh-issledovaniy-patsientov-zhenskogo-pola-s-distsirkulyatornoy
Ovodyuk N., Goryanska K., Ivanchuk A., Kovtunyak A., Griva A., et al. (2022). Features of Cerebral Hemodynamics in Patients After Stroke Depending on the Variability of Blood Pressure and Their Quality of Life. Wiadomosci Lekarskie, 75(5), 1083-1089. https://doi.org/10.36740/WLek202205106
Parfenov V. (2017). Dyscirculatory encephalopathy and vascular cognitive disorders. Moscow.IMA-PRESS, 128(12),1-123. https://nnp.ima-press.net/nnp/article/viewFile/841/732
Parfenov V. (2019). Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy). Neurology, neuropsychiatry, psychosomatics, 11(3), 61-67. https://doi.org/10.14412/2074-2711-2019-3S-61-67
Pizova N. (2022). Cerebrovascular diseases and cognitive impairment: therapeutic approaches. Medical advice. https://doi.org/10.21518/2079-701X-2022-16-21-54-61
Shchukin I., Lebedeva A., Soldatov M., Fidler M. (2018). Clinical and instrumental evaluation of therapy for vascular cognitive disorders. Journal of Neurology and Psychiatry.SS Korsakov, 7,25-29. https://doi.org/10.17116/jnevro20181187125
Shevchenko O., Lakhman O., Katamanova E. (2020). Characteristics of cognitive impairment in alcoholic and dyscirculatory encephalopathy. Clinic for nervous and mental diseases.120(5),16-23. doi: https://doi.org/10.17116/jnevro202012005116
Skvortsov V., Levitan B., Golieva E., Malyakin G. (2021) Dyscirculatory encephalopathy in the practice of a general practitioner. Lvrash,14(41).https://www.lvrach.ru/2021/05/15437943
Velikanov D., Tsoqoyev A.,Serebryakov A.,Çerevaşenko L.,Bobrik Y., et al. (2021). Efficiency of the use of therapeutic physical factors in the outpatient medical rehabilitation of patients with dyscirculatory encephalopathy. Azerbaijan Medical Journal,4,177-185. https://doi.org/10.34921/amj.2021.4.025
Yakovchuk E., & Penina G. (2021). Cognitive functions, quality of life of patients with stage II dyscirculatory encephalopathy in northerners from the ICF position. (Russian). Arterial'naya Gipertenziya, 27(3),351-364. https://doi.org/10.18705/1607-419X-2021-27-3-351-364
Yurieva T., Zaika A., Shprakh V., Zhukova S. (2020). Neurophysiological changes in patients with dyscirculatory encephalopathy in combination with ischemic optic neuropathy. Scientific Biomedical Act,5(4), http://dx.doi.org/10.29413/ABS.2020-5.4.9
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2023 Jorge Eduardo Ochoa Aucay , Erika Pamela Abad Molina, John Paul Castillo Hernández, Martín Alexander Chamorro Romero, Sonia Azucena Ortiz Reinoso, Chrisy Esthephanye Sarmiento Sarmiento
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
